Eurordis Charter for Clinical Trials in Rare Diseases
- June 07
date_published:
June 07
A charter for collaboration between the various stakeholders (sponsors, patient organisations, patients and investigators) involved in clinical trials for rare diseases has been developed by Eurordis through consultation. The aim of the charter is to improve the quality of clinical research in rare diseases and to ensure a transparent and effective dialogue between interested parties.
Glossary of terms >
Languages: English
document:
